These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17316163)

  • 1. Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium.
    Aghdam SY; Barger SW
    Curr Alzheimer Res; 2007 Feb; 4(1):21-31. PubMed ID: 17316163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
    Damri O; Shemesh N; Agam G
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview of the Neurotrophic and Neuroprotective Properties of the Psychoactive Drug Lithium as an Autophagy Modulator in Neurodegenerative Conditions.
    Singh A; Arora S; Chavan M; Shahbaz S; Jabeen H
    Cureus; 2023 Aug; 15(8):e44051. PubMed ID: 37746513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.
    Chiu CT; Chuang DM
    Pharmacol Ther; 2010 Nov; 128(2):281-304. PubMed ID: 20705090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective action of lithium in disorders of the central nervous system.
    Chiu CT; Chuang DM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):461-76. PubMed ID: 21743136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models.
    Kerr F; Bjedov I; Sofola-Adesakin O
    Front Mol Neurosci; 2018; 11():297. PubMed ID: 30210290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of lithium: what are the implications in humans with neurodegenerative disorders?
    Morlet É; Hozer F; Costemale-Lacoste JF
    Geriatr Psychol Neuropsychiatr Vieil; 2018 Mar; 16(1):78-86. PubMed ID: 29400298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
    Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
    Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A systematic analysis of neurobiological roles of lithium].
    Gogoleva IV; Gromova OA; Torshin IY; Grishina TR; Pronin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):17-23. PubMed ID: 36440772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
    Gould TD; Manji HK
    Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium and autophagy.
    Motoi Y; Shimada K; Ishiguro K; Hattori N
    ACS Chem Neurosci; 2014 Jun; 5(6):434-42. PubMed ID: 24738557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glycogen synthase kinase-3β in ketamine-induced developmental neuroapoptosis in rats.
    Liu JR; Baek C; Han XH; Shoureshi P; Soriano SG
    Br J Anaesth; 2013 Jun; 110 Suppl 1():i3-9. PubMed ID: 23533250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new avenue for lithium: intervention in traumatic brain injury.
    Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
    ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium, a potential protective drug in Alzheimer's disease.
    Engel T; Goñi-Oliver P; Gómez de Barreda E; Lucas JJ; Hernández F; Avila J
    Neurodegener Dis; 2008; 5(3-4):247-9. PubMed ID: 18322403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
    Manji HK; Moore GJ; Chen G
    Biol Psychiatry; 1999 Oct; 46(7):929-40. PubMed ID: 10509176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta).
    Serretti A; Drago A; De Ronchi D
    Curr Med Chem; 2009; 16(15):1917-48. PubMed ID: 19442155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kainate-induced toxicity in the hippocampus: potential role of lithium.
    Crespo-Biel N; Camins A; Canudas AM; Pallàs M
    Bipolar Disord; 2010 Jun; 12(4):425-36. PubMed ID: 20636640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
    Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
    Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.